Antibody Titer Against Varicella Zoster Virus and Recombinant Varicella Zoster Vaccine in Hemodialysis Patients: What We Know, What We Should Know

Antibody Titer Against Varicella Zoster Virus and Recombinant Varicella Zoster Vaccine in Hemodialysis Patients: What We Know, What We Should Know

Background: Varicella zoster virus (VZV) infection can be life-threatening for fragile and immunosuppressed patients. Recombinant VZ vaccination (RVZV) has been recommended for vulnerable patients to reduce the risk of reactivation. Hemodialysis (HD) patients often have weakened immune systems and a...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesca K. Martino, Lucia F. Stefanelli, Martina Cacciapuoti, Elisabetta Bettin, Giuseppe Scaparrotta, Laura Gobbi, Dorella Del Prete, Lorenzo A. Calò, Federico Nalesso
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Life
Subjects:
varicella zoster virus
recombinant vaccination
antibody titer
hemodialysis
Online Access:https://www.mdpi.com/2075-1729/15/4/621
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2075-1729/15/4/621

Similar Items